Kris Spassopoulos
About Kris Spassopoulos
Kris Spassopoulos is an Associate Product Manager at Bristol-Myers Squibb in Mulgrave, Victoria, Australia, with extensive experience in sales and product management within the pharmaceutical industry.
Company
Kris Spassopoulos currently holds a position at Bristol-Myers Squibb. Bristol-Myers Squibb is a global biopharmaceutical company known for its innovations in medical research and treatment development. The company's focus ranges from oncology and immunology to cardiovascular diseases. Kris is based in Mulgrave, Victoria, Australia, where he applies his extensive experience in the pharmaceutical industry.
Title
Kris Spassopoulos serves as an Associate Product Manager at Bristol-Myers Squibb. In this role, he contributes to the development and management of pharmaceutical products. His responsibilities likely include market analysis, product strategy, and lifecycle management, leveraging his prior sales experience to optimize product performance.
Work History and Experience
Before becoming an Associate Product Manager, Kris worked as a Senior Specialist Sales Representative at Bristol-Myers Squibb from 2018 to 2020. Prior to that, he held positions at Bayer: from 2016 to 2018 as a Hospital Specialist Representative and from 2013 to 2016 as a Medical Representative. This extensive background in sales and product management in the pharmaceutical industry enables him to bring a wealth of experience to his current role.
Educational Background
Kris Spassopoulos holds significant academic qualifications. He earned a Bachelor of Science with a Double Major in Pharmacology and Physiology from Monash University, where he studied from 2009 to 2012. He further obtained a Bachelor of Medicines Management (Professional Honours) from the University of Tasmania, where he also completed The Medicines Australia Continuing Education Program. His academic foundation is enhanced by his education from Trinity Grammar School, Kew.
Field of Expertise
Kris has been working in the field of Immuno-Oncology since February 2020. His expertise in this cutting-edge area of medical research involves the study and development of treatments for cancer through the body’s immune system. This specialization aligns with the broader goals of Bristol-Myers Squibb in advancing cancer therapies.